Shares of Takeda Pharmaceuticals rose after the Japanese pharmaceutical major announced positive results from clinical trials of its new treatment for plaque psoriasis. The stock climbed 4.3% in early ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...
The China Pharmaceutical Innovation and Invention Index, a new gauge, highlights top drug makers on the mainland for the ...
The expansion will add about one-third more active manufacturing space to Alnylam's production facility in Norton, and it is ...
Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best biotech stocks to buy according to Wall Street analysts.
In today’s Pharmaceutical Executive Daily, Pfizer discloses its 2026 revenue expectations, a bipartisan group of House ...
Turbiscan technology accelerates lipid nanoparticle stability testing and supports robust pharmaceutical formulation ...
The United States and Britain announced a deal on Monday to securezero tariffs on British pharmaceutical products and medical technology in return for Britain spending more on medicines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results